Completed PHASE4 INTERVENTIONAL 3-arm NCT01076478

Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines (ASCEND)

Sponsor: Otsuka Pharmaceutical, Inc., Philippines

Interventions Cilostazol

Updated 5 times since 2017 Last updated: Feb 25, 2010 Started: Mar 31, 2004 Completion: Nov 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Polyneuropathy and is currently completed. Otsuka Pharmaceutical, Inc., Philippines leads this study, which shows 5 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Otsuka Pharmaceutical, Inc., Philippines

Data source: Otsuka Pharmaceutical, Inc., Philippines

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Manila, Philippines